The anti-inflammatory properties of CS, mediated predominantly through monomer CS or glucocorticoid receptor (GR) inhibition of transcription factors such as NF-kB (transrepression) are considered important in DMD therapy. The gene discussed is NR3C1; the disease is Duchenne muscular dystrophy.